Surgery bleeding at caesarean section
Conditions
Interventions
tranexamic group
Control group
Sponsors
federal teaching hospital abakaliki
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Parturients with singleton pregnancy at 37-42 weeks¿ gestational age 2. Patient on admission for elective caesarean section 3. patients without contraindication to tranexamic acid 4. patient who have signed the informed consent
Exclusion criteria
Exclusion criteria: 1. Women who have known allergy to tranexamic acid 2. Women with prior history of thromboembolism 3. Women with bleeding disorders 4. Patients with renal disease 5. Patients with liver pathology 6. Patients with chronic hypertension 7. Patients with preeclampsia/eclampsia 8. Women with antepartum haemorrhage 9. Patients with varicose veins at increased risk of deep vein thrombosis 10. Patients who do not consent to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimated blood loss at elective Caesarean section | — |
Secondary
| Measure | Time frame |
|---|---|
| Excessive blood at Caesarean section loss defined as blood loss > 1000ml;Change in haematocrit after Caesarean section ;The need for additional uterotonics to control bleeding;The need for blood transfusion during or after the surgery;any maternal side effects | — |
Countries
Nigeria
Contacts
Public Contactchristian mgbafulu
none
Outcome results
None listed